London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation ...

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of ...

The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

At the Financial Times (FT) Global Pharma and Biotech Summit in London on 6 November, GSK CEO Emma Walmsley addressed these concerns and underscored the critical role of the US in GSK’s operations.

(Alliance News) - GSK PLC on Tuesday said applications for its treatment for a type of asthma and chronic rhinosinusitis with nasal polyps, or CRSwNP, have been accepted for review in China, Japan and ...

GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I've ...

The UK drugmaker plans to bring the IDRx drug into late stage trials later this year. GSK shares were little changed in early London trading, reflecting their performance so far this year. When asked ...

(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or ...

Lacalle Pou “welcomed GSK's announcement of the opening of one ... The UK “encouraged exploring the cross-issuance of this bond in London to access the ample global capital funds present ...